People_

Dr Eric Hau

Clinical Associate Professor
Sydney Medical School
Westmead Clinical School
Faculty of Medicine and Health

Email

eric.hau@sydney.edu.au

Themes

Cancer

Keywords

Biostatistics, Brain tumours, Cell biology, Genetics, Lung cancer

Approaches

Cellular/Molecular, Clinical Trials, Metabolism

Clinical speciality

Oncology

Publications

By Type

Expand all

Journals

Magon, H., Gholam Rezaei, L., Lee, Y., Smith, J., Besson, J., Hau, E., Taylor, S., Ruben, J., Jones, D., Mabb, K., et al (2024). Adapting to change: exploring perceptions and demands of the coronavirus (COVID-19) workforce changes - an Australian multi-institutional radiation oncology survey. Australian Health Review, 48(4), 388-395. [More Information]
Chin, V., Delaney, G., Vinod, S., Chlap, P., Finnegan, R., Hau, E., Ong, A., Ma, X., Descallar, J., Otton, J., Holloway, L. (2024). Cardiac Substructure Dose and Survival in Stereotactic Radiotherapy for Lung Cancer: Results of the Multi-Centre SSBROC Trial. Clinical Oncology. [More Information]
Field, M., Lehmann, J., Ludbrook, J., Miller, A., Rezo, A., Selvaraj, J., Sykes, J., Thwaites, D., Holloway, L., Vinod, S., Hau, E., et al (2024). Federated Learning Survival Model and Potential Radiotherapy Decision Support Impact Assessment for Non–small Cell Lung Cancer Using Real-World Data. Clinical Oncology, 36(7), e197-e208. [More Information]
Brown, L., Khou, V., Brown, C., Alexander, M., Jayamanne, D., Wei, J., Gray, L., Chan, W., Smith, S., Harden, S., Mersiades, T., Itchins, M., Pavlakis, N., Clarke, S., Boyer, M., Nagrial, A., Hau, E., Esteves Domingues Pires da Silva, I., Kao, S., Kong, B., et al (2024). First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study. Frontiers in Oncology, 14. [More Information]
Chong, L., Tan, S., Senthil Kumar, K., Hau, E., Vellayappan, B., Blasiak, A., Ho, D., Wang, P., Lee, V., Vijayakumar, S., et al (2024). Radiation therapy with phenotypic medicine: towards N-of-1 personalization. British Journal of Cancer, 131(1), 1-10. [More Information]
Brown, L., Ahn, J., Gao, B., Gee, H., Nagrial, A., Hau, E., Esteves Domingues Pires da Silva, I. (2024). Site-Specific Response and Resistance Patterns in Patients with Advanced Non-Small-Cell Lung Cancer Treated with First-Line Systemic Therapy. Cancers, 16(11). [More Information]
Ahn, J., Last, A., Dwyer, P., Ong, A., Aherne, N., Azzi, M., Hau, E., Yeghiaian Alvandi, R., Hegi, F., Browne, L., Gee, H., et al (2023). SABR for Early Non-Small Cell Lung Cancer: Changes in Pulmonary Function, Dyspnea, and Quality of Life. International Journal of Radiation Oncology Biology Physics, 117(5), 1213-1221. [More Information]
Boys, E., Gao, B., Hui, R., Esteves Domingues Pires da Silva, I., Hau, E., Gee, H., Nagrial, A. (2023). Use of durvalumab in stage III non-small-cell lung cancer based on eligibility for the PACIFIC study. Thoracic Cancer, 14(6), 563-572. [More Information]
Lee, K., Le, T., Hau, E., Hanna, G., Gee, H., Vinod, S., Dammak, S., Palma, D., Ong, A., Yeghiaian-Alvandi, R., et al (2022). A Systematic Review Into the Radiologic Features Predicting Local Recurrence After Stereotactic Ablative Body Radiotherapy (SABR) in Patients With Non-Small Cell Lung Cancer (NSCLC). International Journal of Radiation Oncology Biology Physics, 113(1), 40-59. [More Information]
Merie, R., Gee, H., Hau, E., Vinod, S. (2022). An Overview of the Role of Radiotherapy in the Treatment of Small Cell Lung Cancer – A Mainstay of Treatment or a Modality in Decline? Clinical Oncology, 34(11), 741-752. [More Information]
Mudassar, F., Shen, H., Cook, K., Hau, E. (2022). Improving the synergistic combination of programmed death-1/programmed death ligand-1 blockade and radiotherapy by targeting the hypoxic tumour microenvironment. Journal of Medical Imaging and Radiation Oncology, 66(4), 560-574. [More Information]
Lee, N., Shafiq, J., Field, M., Fiddler, C., Varadarajan, S., Gandhidasan, S., Hau, E., Vinod, S. (2022). Predicting 2-year survival in stage I-III non-small cell lung cancer: the development and validation of a scoring system from an Australian cohort. Radiation Oncology, 17(1). [More Information]
Hau, E., Lim, R., Vinod, S., Nahar, N., Gee, H., Pinkham, M. (2022). Radiation therapy in the prevention and management of brain metastases in patients with small cell lung cancer: a narrative review. Chinese Clinical Oncology, 11(2). [More Information]
Field, M., Vinod, S., Aherne, N., Carolan, M., Dekker, A., Delaney, G., Greenham, S., Hau, E., Lehmann, J., Ludbrook, J., Sykes, J., Holloway, L., Thwaites, D., et al (2021). Implementation of the Australian Computer-Assisted Theragnostics (AusCAT) network for radiation oncology data extraction, reporting and distributed learning. Journal of Medical Imaging and Radiation Oncology, 65(5), 627-636. [More Information]
Di Re, A., Sun, Y., Sundaresan, P., Hau, E., Toh, J., Gee, H., Or, M., Haworth, A. (2021). MRI radiomics in the prediction of therapeutic response to neoadjuvant therapy for locoregionally advanced rectal cancer: a systematic review. Expert Review of Anticancer Therapy, 21(4), 425-449. [More Information]
Khalil, A., Hau, E., Gebski, V., Grau, C., Gee, H., Nyeng, T., West, K., Kramer, S., Farlow, D., Knap, M., et al (2021). Personal innovative approach in radiation therapy of lung cancer- functional lung avoidance SPECT-guided (ASPECT) radiation therapy: a study protocol for phase II randomised double-blind clinical trial. BMC Cancer, 21(1), 940. [More Information]
Cook, K., Shen, H., McKelvey, K., Gee, H., Hau, E. (2021). Targeting glucose metabolism of cancer cells with dichloroacetate to radiosensitize high-grade gliomas. International Journal of Molecular Sciences, 22(14), 7265-1-7265-15. [More Information]
Hau, E., Hegi-Johnson, F., Atkinson, C., Barber, J., Browne, L., Chin, Y., Dwyer, P., Graham, P., O'Hare, J., Lu, D., et al (2020). Collaborative implementation of stereotactic ablative body radiotherapy: A model for the safe implementation of complex radiotherapy techniques in Australia. Asia-Pacific Journal of Clinical Oncology, 16(1), 39-44. [More Information]
Shen, H., Cook, K., Gee, H., Hau, E. (2020). Hypoxia, metabolism, and the circadian clock: new links to overcome radiation resistance in high-grade gliomas. Journal of Experimental and Clinical Cancer Research, 39(1), 1-14. [More Information]
Sia, J., Szmyd, R., Hau, E., Gee, H. (2020). Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer. Frontiers in Cell and Developmental Biology, 8, 41. [More Information]
Vinod, S., Hau, E. (2020). Radiotherapy treatment for lung cancer: Current status and future directions. Respirology, 25(S2), 61-71. [More Information]
Dhawan, A., Scott, J., Sundaresan, P., Veness, M., Porceddu, S., Hau, E., Harris, A., Buffa, F., Gee, H. (2020). Role of gene signatures combined with pathology in classification of oropharynx head and neck cancer. Scientific Reports, 10(1), 1-10. [More Information]
Mudassar, F., Shen, H., O'Neill, G., Hau, E. (2020). Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas. Journal of Experimental and Clinical Cancer Research, 39(1), 208. [More Information]
Wong, E., Nahar, N., Hau, E., Varikatt, W., Gebski, V., Ng, T., Jayamohan, J., Sundaresan, P. (2019). Cut-point for Ki-67 proliferation index as a prognostic marker for glioblastoma. Asia-Pacific Journal of Clinical Oncology, 15(1), 5-9. [More Information]
Farr, K., West, K., Yeghiaian-Alvandi, R., Farlow, D., Stensmyr, R., Chicco, A., Hau, E. (2019). Functional perfusion image guided radiation treatment planning for locally advanced lung cancer. Physics And Imaging In Radiation Oncology, 11, 76-81. [More Information]
Salkeld, A., Hau, E., Nahar, N., Sykes, J., Wang, T., Thwaites, D. (2018). Changes in brain metastasis during radiosurgical planning. International Journal of Radiation Oncology Biology Physics, 102(4), 727-733. [More Information]
Bongers, A., Hau, E., Shen, H. (2018). Short Diffusion Time Diffusion-Weighted Imaging With Oscillating Gradient Preparation as an Early Magnetic Resonance Imaging Biomarker for Radiation Therapy Response Monitoring in Glioblastoma: A Preclinical Feasibility Study. International Journal of Radiation Oncology Biology Physics, 102(4), 1014-1023. [More Information]
Merie, R., Browne, L., Cardoso, J., Cardoso, M., Chin, Y., Clark, C., Graham, P., Szwajcer, A., Hau, E. (2017). Proposal for a gold standard for cosmetic evaluation after breast conserving therapy: Results from the St George and Wollongong Breast Boost trial. Journal of Medical Imaging and Radiation Oncology, 61(6), 819-825. [More Information]

show 25 more

By Year

Expand all

2024

Magon, H., Gholam Rezaei, L., Lee, Y., Smith, J., Besson, J., Hau, E., Taylor, S., Ruben, J., Jones, D., Mabb, K., et al (2024). Adapting to change: exploring perceptions and demands of the coronavirus (COVID-19) workforce changes - an Australian multi-institutional radiation oncology survey. Australian Health Review, 48(4), 388-395. [More Information]
Chin, V., Delaney, G., Vinod, S., Chlap, P., Finnegan, R., Hau, E., Ong, A., Ma, X., Descallar, J., Otton, J., Holloway, L. (2024). Cardiac Substructure Dose and Survival in Stereotactic Radiotherapy for Lung Cancer: Results of the Multi-Centre SSBROC Trial. Clinical Oncology. [More Information]
Field, M., Lehmann, J., Ludbrook, J., Miller, A., Rezo, A., Selvaraj, J., Sykes, J., Thwaites, D., Holloway, L., Vinod, S., Hau, E., et al (2024). Federated Learning Survival Model and Potential Radiotherapy Decision Support Impact Assessment for Non–small Cell Lung Cancer Using Real-World Data. Clinical Oncology, 36(7), e197-e208. [More Information]
Brown, L., Khou, V., Brown, C., Alexander, M., Jayamanne, D., Wei, J., Gray, L., Chan, W., Smith, S., Harden, S., Mersiades, T., Itchins, M., Pavlakis, N., Clarke, S., Boyer, M., Nagrial, A., Hau, E., Esteves Domingues Pires da Silva, I., Kao, S., Kong, B., et al (2024). First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study. Frontiers in Oncology, 14. [More Information]
Chong, L., Tan, S., Senthil Kumar, K., Hau, E., Vellayappan, B., Blasiak, A., Ho, D., Wang, P., Lee, V., Vijayakumar, S., et al (2024). Radiation therapy with phenotypic medicine: towards N-of-1 personalization. British Journal of Cancer, 131(1), 1-10. [More Information]
Brown, L., Ahn, J., Gao, B., Gee, H., Nagrial, A., Hau, E., Esteves Domingues Pires da Silva, I. (2024). Site-Specific Response and Resistance Patterns in Patients with Advanced Non-Small-Cell Lung Cancer Treated with First-Line Systemic Therapy. Cancers, 16(11). [More Information]

show 3 more

2023

Ahn, J., Last, A., Dwyer, P., Ong, A., Aherne, N., Azzi, M., Hau, E., Yeghiaian Alvandi, R., Hegi, F., Browne, L., Gee, H., et al (2023). SABR for Early Non-Small Cell Lung Cancer: Changes in Pulmonary Function, Dyspnea, and Quality of Life. International Journal of Radiation Oncology Biology Physics, 117(5), 1213-1221. [More Information]
Boys, E., Gao, B., Hui, R., Esteves Domingues Pires da Silva, I., Hau, E., Gee, H., Nagrial, A. (2023). Use of durvalumab in stage III non-small-cell lung cancer based on eligibility for the PACIFIC study. Thoracic Cancer, 14(6), 563-572. [More Information]

2022

Lee, K., Le, T., Hau, E., Hanna, G., Gee, H., Vinod, S., Dammak, S., Palma, D., Ong, A., Yeghiaian-Alvandi, R., et al (2022). A Systematic Review Into the Radiologic Features Predicting Local Recurrence After Stereotactic Ablative Body Radiotherapy (SABR) in Patients With Non-Small Cell Lung Cancer (NSCLC). International Journal of Radiation Oncology Biology Physics, 113(1), 40-59. [More Information]
Merie, R., Gee, H., Hau, E., Vinod, S. (2022). An Overview of the Role of Radiotherapy in the Treatment of Small Cell Lung Cancer – A Mainstay of Treatment or a Modality in Decline? Clinical Oncology, 34(11), 741-752. [More Information]
Mudassar, F., Shen, H., Cook, K., Hau, E. (2022). Improving the synergistic combination of programmed death-1/programmed death ligand-1 blockade and radiotherapy by targeting the hypoxic tumour microenvironment. Journal of Medical Imaging and Radiation Oncology, 66(4), 560-574. [More Information]
Lee, N., Shafiq, J., Field, M., Fiddler, C., Varadarajan, S., Gandhidasan, S., Hau, E., Vinod, S. (2022). Predicting 2-year survival in stage I-III non-small cell lung cancer: the development and validation of a scoring system from an Australian cohort. Radiation Oncology, 17(1). [More Information]
Hau, E., Lim, R., Vinod, S., Nahar, N., Gee, H., Pinkham, M. (2022). Radiation therapy in the prevention and management of brain metastases in patients with small cell lung cancer: a narrative review. Chinese Clinical Oncology, 11(2). [More Information]

show 2 more

2021

Field, M., Vinod, S., Aherne, N., Carolan, M., Dekker, A., Delaney, G., Greenham, S., Hau, E., Lehmann, J., Ludbrook, J., Sykes, J., Holloway, L., Thwaites, D., et al (2021). Implementation of the Australian Computer-Assisted Theragnostics (AusCAT) network for radiation oncology data extraction, reporting and distributed learning. Journal of Medical Imaging and Radiation Oncology, 65(5), 627-636. [More Information]
Di Re, A., Sun, Y., Sundaresan, P., Hau, E., Toh, J., Gee, H., Or, M., Haworth, A. (2021). MRI radiomics in the prediction of therapeutic response to neoadjuvant therapy for locoregionally advanced rectal cancer: a systematic review. Expert Review of Anticancer Therapy, 21(4), 425-449. [More Information]
Khalil, A., Hau, E., Gebski, V., Grau, C., Gee, H., Nyeng, T., West, K., Kramer, S., Farlow, D., Knap, M., et al (2021). Personal innovative approach in radiation therapy of lung cancer- functional lung avoidance SPECT-guided (ASPECT) radiation therapy: a study protocol for phase II randomised double-blind clinical trial. BMC Cancer, 21(1), 940. [More Information]
Cook, K., Shen, H., McKelvey, K., Gee, H., Hau, E. (2021). Targeting glucose metabolism of cancer cells with dichloroacetate to radiosensitize high-grade gliomas. International Journal of Molecular Sciences, 22(14), 7265-1-7265-15. [More Information]

show 1 more

2020

Hau, E., Hegi-Johnson, F., Atkinson, C., Barber, J., Browne, L., Chin, Y., Dwyer, P., Graham, P., O'Hare, J., Lu, D., et al (2020). Collaborative implementation of stereotactic ablative body radiotherapy: A model for the safe implementation of complex radiotherapy techniques in Australia. Asia-Pacific Journal of Clinical Oncology, 16(1), 39-44. [More Information]
Shen, H., Cook, K., Gee, H., Hau, E. (2020). Hypoxia, metabolism, and the circadian clock: new links to overcome radiation resistance in high-grade gliomas. Journal of Experimental and Clinical Cancer Research, 39(1), 1-14. [More Information]
Sia, J., Szmyd, R., Hau, E., Gee, H. (2020). Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer. Frontiers in Cell and Developmental Biology, 8, 41. [More Information]
Vinod, S., Hau, E. (2020). Radiotherapy treatment for lung cancer: Current status and future directions. Respirology, 25(S2), 61-71. [More Information]
Dhawan, A., Scott, J., Sundaresan, P., Veness, M., Porceddu, S., Hau, E., Harris, A., Buffa, F., Gee, H. (2020). Role of gene signatures combined with pathology in classification of oropharynx head and neck cancer. Scientific Reports, 10(1), 1-10. [More Information]
Mudassar, F., Shen, H., O'Neill, G., Hau, E. (2020). Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas. Journal of Experimental and Clinical Cancer Research, 39(1), 208. [More Information]

show 3 more

2019

Wong, E., Nahar, N., Hau, E., Varikatt, W., Gebski, V., Ng, T., Jayamohan, J., Sundaresan, P. (2019). Cut-point for Ki-67 proliferation index as a prognostic marker for glioblastoma. Asia-Pacific Journal of Clinical Oncology, 15(1), 5-9. [More Information]
Farr, K., West, K., Yeghiaian-Alvandi, R., Farlow, D., Stensmyr, R., Chicco, A., Hau, E. (2019). Functional perfusion image guided radiation treatment planning for locally advanced lung cancer. Physics And Imaging In Radiation Oncology, 11, 76-81. [More Information]

2018

Salkeld, A., Hau, E., Nahar, N., Sykes, J., Wang, T., Thwaites, D. (2018). Changes in brain metastasis during radiosurgical planning. International Journal of Radiation Oncology Biology Physics, 102(4), 727-733. [More Information]
Bongers, A., Hau, E., Shen, H. (2018). Short Diffusion Time Diffusion-Weighted Imaging With Oscillating Gradient Preparation as an Early Magnetic Resonance Imaging Biomarker for Radiation Therapy Response Monitoring in Glioblastoma: A Preclinical Feasibility Study. International Journal of Radiation Oncology Biology Physics, 102(4), 1014-1023. [More Information]

2017

Merie, R., Browne, L., Cardoso, J., Cardoso, M., Chin, Y., Clark, C., Graham, P., Szwajcer, A., Hau, E. (2017). Proposal for a gold standard for cosmetic evaluation after breast conserving therapy: Results from the St George and Wollongong Breast Boost trial. Journal of Medical Imaging and Radiation Oncology, 61(6), 819-825. [More Information]

Selected Grants

2022

A flagship lightsheet, confocal and live cell 4D microscope to turbocharge translational cancer research at the Westmead Health Precinct, George J, Graham J, Robinson P, O'Neill G, Hau E, Fernandez Penas P, Gottlieb D, Ahern V, Cesare A, Schlegel P, Cancer Institute NSW/Equipment Grant

2020

Understanding the molecular mechanisms of cell death in radiotherapy, Cesare A, Gee H, Hau E, National Health and Medical Research Council (NHMRC)/Ideas Grant

2019

Targeting hypoxia and mitochondrial metabolism as an approach of radiosensitisation for diffuse intrinsic pontine gliomas DIPG, Hau E, Shen H, McKelvey K, Mark Hughes Foundation Ltd/Project Grant

Page not found